Direct repression of FLIP expression by c-myc is a major determinant of TRAIL sensitivity

Molecular and Cellular Biology
M Stacey RicciWafik S El-Deiry

Abstract

Tumor necrosis factor alpha (TNF-alpha)-related apoptosis-inducing ligand (TRAIL) is a member of the TNF-alpha family of death receptor ligands and holds great therapeutic potential as a tumor cell-specific cytotoxic agent. Using a panel of established tumor cell lines and normal cells, we found a significant difference between the number of TRAIL-sensitive cells expressing high levels of c-myc and TRAIL-resistant cells expressing low levels of c-myc (P < 0.05, n = 19). We also found a direct linear correlation between c-myc levels and TRAIL sensitivity in TRAIL-sensitive cell lines (r = 0.94, n = 6). Overexpression of c-myc or activation of a myc-estrogen receptor (ER) fusion sensitized TRAIL-resistant cells to TRAIL. Conversely, small interfering RNA (siRNA)-mediated knockdown of c-myc significantly reduced both c-myc expression and TRAIL-induced apoptosis. The gene encoding the inhibitor of caspase activation, FLICE inhibitory protein (FLIP), appears to be a direct target of c-myc-mediated transcriptional repression. Overexpression of c-myc or activation of myc-estrogen receptor (ER) decreased FLIP levels both in cell culture and in mouse models of c-myc-induced tumorigenesis, while knocking down c-myc using siRNA increased ...Continue Reading

References

Apr 3, 1992·Cell·G I EvanD C Hancock
Jan 1, 1990·Advances in Cancer Research·I Magrath
May 1, 1997·Molecular and Cellular Biology·K E Boyd, P J Farnham
Jul 10, 1997·Nature·M IrmlerJ Tschopp
Apr 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·T C HeB Vogelstein
May 16, 1998·The Journal of Clinical Investigation·C SevignaniB Calabretta
Aug 28, 1998·Science·A Ashkenazi, V M Dixit
Feb 18, 1999·Molecular and Cellular Biology·I K RufJ T Sample
Jun 23, 1999·Oncogene·C E NesbitE V Prochownik
Jul 20, 1999·The Journal of Clinical Investigation·A AshkenaziR H Schwall
Oct 6, 1999·The Journal of Experimental Medicine·J P MedemaR Offringa
Mar 29, 2001·Proceedings of the National Academy of Sciences of the United States of America·D XuM Henriksson
Apr 3, 2001·Nature Medicine·D LawrenceA Ashkenazi
Jun 21, 2001·Molecular and Cellular Biology·E L SoucieL Z Penn
Jul 5, 2001·Molecular and Cellular Biology·C M EischenJ L Cleveland
Aug 21, 2001·The Journal of Investigative Dermatology·R R BullaniL E French
Nov 1, 2001·Cell Death and Differentiation·W S El-Deiry
Nov 13, 2001·Oncogene·C M EischenJ L Cleveland
Nov 20, 2001·Molecular and Cellular Biology·A KruegerS Kirchhoff
Apr 12, 2002·The American Journal of Pathology·Roman Kurt ThomasJürgen Wolf
May 2, 2002·Proceedings of the National Academy of Sciences of the United States of America·Antje Menssen, Heiko Hermeking
Aug 9, 2002·Molecular and Cellular Biology·Philippe JuinGerard Evan
Sep 7, 2002·The Journal of Biological Chemistry·Olivier MicheauMarkus G Grütter
Oct 3, 2002·Nature Reviews. Cancer·Stella PelengarisGerard Evan
Oct 17, 2002·Genes & Development·Jennifer E F Butler, James T Kadonaga
Nov 14, 2002·Laboratory Investigation; a Journal of Technical Methods and Pathology·Fanny Baran-MarszakJean Feuillard

❮ Previous
Next ❯

Citations

Jul 6, 2006·Apoptosis : an International Journal on Programmed Cell Death·Alessandra CucinaMariano Bizzarri
May 6, 2008·Apoptosis : an International Journal on Programmed Cell Death·Geoffrey E JohnsonTom K Hei
Sep 28, 2005·Breast Cancer Research and Treatment·Archana ThakurJoshua D Liao
Sep 25, 2008·Nature Reviews. Cancer·Ricky W JohnstoneMark J Smyth
Nov 8, 2008·Nature Reviews. Drug Discovery·Avi Ashkenazi
Feb 3, 2005·Nature Reviews. Immunology·Mariapia A Degli-Esposti, Mark J Smyth
Feb 25, 2006·Nature Reviews. Immunology·Ralph C BuddJürg Tschopp
Oct 29, 2008·Oncogene·B Hoffman, D A Liebermann
Aug 1, 2008·Proceedings of the National Academy of Sciences of the United States of America·Kazuyoshi TakedaKo Okumura
Dec 19, 2009·The Journal of Biological Chemistry·Yongjun FanWei-Xing Zong
Aug 13, 2013·Human Molecular Genetics·Pearl P C TohDavid C Rubinsztein
Aug 13, 2013·Nucleic Acids Research·Gautier StollOlivier Delattre
Aug 9, 2006·Molecular and Cellular Biology·Amith PannerRussell O Pieper
Oct 4, 2005·Molecular and Cellular Biology·Amith PannerRussell O Pieper
Oct 3, 2007·Cancer Research·Xiaoping ZhangAria F Olumi
Feb 19, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Manonmani GanapathyAddanki P Kumar
Dec 15, 2007·The Journal of Clinical Investigation·Niklas FinnbergWafik S El-Deiry
Jun 5, 2008·The Journal of Clinical Investigation·Avi Ashkenazi, Roy S Herbst
Jul 25, 2009·Blood·Kay KlapprothThomas Wirth
Dec 15, 2010·Future Oncology·Hendrik J Kuiken, Roderick L Beijersbergen
Oct 8, 2005·Proceedings of the National Academy of Sciences of the United States of America·Sabine RottmannKim C Quon
Sep 21, 2005·Proceedings of the National Academy of Sciences of the United States of America·Xiao-Yong ZhangSteven B McMahon
Aug 14, 2012·EMBO Molecular Medicine·Apana A L TakwiYong Li
May 29, 2010·Cellular and Molecular Life Sciences : CMLS·Guillaume JacqueminOlivier Micheau
Sep 13, 2006·Leukemia & Lymphoma·Federica CoralliniPaola Secchiero
May 26, 2015·Expert Opinion on Therapeutic Targets·Bora LimWafik S El-Deiry
Jun 5, 2007·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Andrew Thorburn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis